Concepts (296)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 19 | 2019 | 411 | 2.860 |
Why?
|
| Mammography | 12 | 2017 | 43 | 2.160 |
Why?
|
| Kidney Failure, Chronic | 18 | 2021 | 127 | 2.030 |
Why?
|
| Racism | 4 | 2022 | 33 | 1.840 |
Why?
|
| Early Detection of Cancer | 5 | 2018 | 105 | 1.710 |
Why?
|
| Healthcare Disparities | 7 | 2023 | 87 | 1.690 |
Why?
|
| Health Services Accessibility | 14 | 2021 | 114 | 1.660 |
Why?
|
| Registries | 17 | 2011 | 199 | 1.530 |
Why?
|
| Renal Replacement Therapy | 10 | 2011 | 18 | 1.530 |
Why?
|
| Health Status Disparities | 5 | 2020 | 79 | 1.510 |
Why?
|
| Kidney Transplantation | 9 | 2021 | 119 | 1.400 |
Why?
|
| Medically Uninsured | 2 | 2021 | 13 | 1.210 |
Why?
|
| Physicians | 2 | 2022 | 124 | 1.070 |
Why?
|
| Humans | 77 | 2023 | 27174 | 0.970 |
Why?
|
| Primary Health Care | 3 | 2021 | 85 | 0.880 |
Why?
|
| Practice Patterns, Physicians' | 5 | 2018 | 110 | 0.870 |
Why?
|
| Health Facilities | 1 | 2023 | 23 | 0.810 |
Why?
|
| Middle Aged | 44 | 2021 | 9039 | 0.800 |
Why?
|
| Health Equity | 1 | 2023 | 18 | 0.800 |
Why?
|
| Female | 57 | 2021 | 15277 | 0.790 |
Why?
|
| Academic Medical Centers | 2 | 2021 | 133 | 0.790 |
Why?
|
| Renal Dialysis | 11 | 2021 | 86 | 0.780 |
Why?
|
| Chicago | 23 | 2019 | 949 | 0.780 |
Why?
|
| Human Rights | 1 | 2022 | 3 | 0.770 |
Why?
|
| Referral and Consultation | 3 | 2021 | 89 | 0.740 |
Why?
|
| Delivery of Health Care | 1 | 2023 | 146 | 0.730 |
Why?
|
| Ambulatory Care Facilities | 1 | 2021 | 39 | 0.720 |
Why?
|
| Community Health Services | 1 | 2021 | 34 | 0.710 |
Why?
|
| Health Personnel | 1 | 2022 | 99 | 0.710 |
Why?
|
| Socioeconomic Factors | 12 | 2020 | 305 | 0.710 |
Why?
|
| Dyslipidemias | 2 | 2018 | 16 | 0.710 |
Why?
|
| Adult | 37 | 2021 | 7921 | 0.700 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2018 | 55 | 0.680 |
Why?
|
| Cardiovascular Diseases | 4 | 2018 | 324 | 0.660 |
Why?
|
| Hospitalization | 2 | 2022 | 306 | 0.650 |
Why?
|
| Mass Screening | 10 | 2017 | 174 | 0.650 |
Why?
|
| Emergency Service, Hospital | 4 | 2022 | 270 | 0.640 |
Why?
|
| Cancer Care Facilities | 1 | 2019 | 7 | 0.630 |
Why?
|
| Carcinoma, Ductal | 1 | 2019 | 4 | 0.630 |
Why?
|
| Cholesterol, LDL | 2 | 2018 | 29 | 0.610 |
Why?
|
| Practice Guidelines as Topic | 7 | 2018 | 261 | 0.590 |
Why?
|
| Aged | 33 | 2021 | 9094 | 0.590 |
Why?
|
| Social Determinants of Health | 1 | 2018 | 33 | 0.580 |
Why?
|
| Violence | 1 | 2018 | 39 | 0.580 |
Why?
|
| Survival Rate | 7 | 2011 | 344 | 0.580 |
Why?
|
| Mortality | 5 | 2018 | 93 | 0.530 |
Why?
|
| Multicenter Studies as Topic | 3 | 2010 | 44 | 0.500 |
Why?
|
| United Kingdom | 12 | 2011 | 49 | 0.490 |
Why?
|
| Residence Characteristics | 5 | 2019 | 216 | 0.480 |
Why?
|
| Health Policy | 2 | 2015 | 41 | 0.480 |
Why?
|
| Undocumented Immigrants | 1 | 2015 | 2 | 0.480 |
Why?
|
| Value of Life | 1 | 2015 | 1 | 0.480 |
Why?
|
| Insurance Coverage | 1 | 2015 | 15 | 0.470 |
Why?
|
| Pregnancy Outcome | 3 | 2014 | 21 | 0.470 |
Why?
|
| Male | 33 | 2021 | 14830 | 0.440 |
Why?
|
| Peritoneal Dialysis | 3 | 2011 | 26 | 0.440 |
Why?
|
| Young Adult | 13 | 2021 | 2026 | 0.430 |
Why?
|
| Hospitals | 4 | 2022 | 167 | 0.420 |
Why?
|
| Cause of Death | 4 | 2011 | 65 | 0.410 |
Why?
|
| Waiting Lists | 2 | 2010 | 18 | 0.410 |
Why?
|
| Outpatient Clinics, Hospital | 4 | 2002 | 15 | 0.400 |
Why?
|
| United States | 10 | 2021 | 2069 | 0.400 |
Why?
|
| Community Health Planning | 2 | 2009 | 20 | 0.390 |
Why?
|
| Tissue Donors | 2 | 2010 | 79 | 0.380 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2019 | 633 | 0.380 |
Why?
|
| Cross-Sectional Studies | 4 | 2021 | 903 | 0.370 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2019 | 803 | 0.370 |
Why?
|
| Retrospective Studies | 12 | 2021 | 3546 | 0.370 |
Why?
|
| Hemoglobins | 4 | 2009 | 33 | 0.360 |
Why?
|
| Adolescent | 9 | 2021 | 2179 | 0.350 |
Why?
|
| National Health Programs | 2 | 2010 | 3 | 0.340 |
Why?
|
| Cesarean Section | 4 | 2014 | 29 | 0.340 |
Why?
|
| Renal Insufficiency | 1 | 2010 | 13 | 0.340 |
Why?
|
| Risk Assessment | 7 | 2018 | 628 | 0.330 |
Why?
|
| Risk Factors | 11 | 2018 | 2336 | 0.330 |
Why?
|
| Community Participation | 1 | 2009 | 17 | 0.320 |
Why?
|
| ErbB Receptors | 1 | 2009 | 55 | 0.310 |
Why?
|
| Aged, 80 and over | 12 | 2018 | 4834 | 0.310 |
Why?
|
| Breech Presentation | 1 | 2008 | 3 | 0.310 |
Why?
|
| Version, Fetal | 1 | 2008 | 3 | 0.310 |
Why?
|
| Incidence | 9 | 2019 | 763 | 0.300 |
Why?
|
| Medical Audit | 1 | 2008 | 5 | 0.300 |
Why?
|
| Pregnancy | 8 | 2020 | 331 | 0.290 |
Why?
|
| Smoking | 2 | 2005 | 183 | 0.270 |
Why?
|
| Hospitals, Public | 6 | 2002 | 27 | 0.270 |
Why?
|
| Poverty | 6 | 2010 | 95 | 0.270 |
Why?
|
| Diabetes Mellitus | 3 | 2005 | 129 | 0.270 |
Why?
|
| Annual Reports as Topic | 3 | 2010 | 3 | 0.250 |
Why?
|
| Guideline Adherence | 3 | 2018 | 57 | 0.250 |
Why?
|
| Intubation | 1 | 2005 | 6 | 0.250 |
Why?
|
| Heroin Dependence | 1 | 2005 | 9 | 0.250 |
Why?
|
| Cocaine-Related Disorders | 1 | 2005 | 13 | 0.250 |
Why?
|
| Public Health | 2 | 2017 | 71 | 0.250 |
Why?
|
| Extraction, Obstetrical | 2 | 1995 | 2 | 0.240 |
Why?
|
| Tobacco Use Disorder | 1 | 2005 | 18 | 0.240 |
Why?
|
| Smoking Cessation | 1 | 2005 | 46 | 0.230 |
Why?
|
| Geographic Information Systems | 1 | 2004 | 4 | 0.230 |
Why?
|
| Diabetes, Gestational | 2 | 2014 | 8 | 0.220 |
Why?
|
| Time Factors | 6 | 2018 | 1438 | 0.220 |
Why?
|
| Age Factors | 6 | 2018 | 776 | 0.220 |
Why?
|
| Treatment Outcome | 5 | 2018 | 3525 | 0.220 |
Why?
|
| Health Status Indicators | 1 | 2004 | 70 | 0.220 |
Why?
|
| New Zealand | 6 | 2019 | 11 | 0.220 |
Why?
|
| Cities | 3 | 2018 | 17 | 0.210 |
Why?
|
| Asthma | 1 | 2005 | 157 | 0.210 |
Why?
|
| Commerce | 1 | 2023 | 12 | 0.200 |
Why?
|
| Uterine Cervical Neoplasms | 5 | 1994 | 33 | 0.200 |
Why?
|
| Patient Transfer | 2 | 1996 | 23 | 0.200 |
Why?
|
| Uncompensated Care | 1 | 2002 | 2 | 0.200 |
Why?
|
| Databases, Factual | 3 | 2019 | 351 | 0.190 |
Why?
|
| Delivery, Obstetric | 2 | 2019 | 12 | 0.190 |
Why?
|
| Morbidity | 2 | 2001 | 54 | 0.190 |
Why?
|
| Health Priorities | 1 | 2001 | 4 | 0.190 |
Why?
|
| Public Health Administration | 1 | 2001 | 9 | 0.190 |
Why?
|
| Patient Compliance | 3 | 2018 | 150 | 0.180 |
Why?
|
| Social Class | 3 | 2010 | 64 | 0.180 |
Why?
|
| Aftercare | 1 | 2021 | 24 | 0.180 |
Why?
|
| Health Surveys | 3 | 2007 | 88 | 0.170 |
Why?
|
| Research Design | 2 | 2020 | 187 | 0.170 |
Why?
|
| Dystocia | 1 | 2020 | 1 | 0.170 |
Why?
|
| England | 5 | 2011 | 16 | 0.160 |
Why?
|
| Neoplasms | 2 | 2017 | 241 | 0.160 |
Why?
|
| Income | 2 | 2005 | 81 | 0.160 |
Why?
|
| Cholesterol | 2 | 2018 | 63 | 0.160 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2011 | 80 | 0.160 |
Why?
|
| Sociology, Medical | 1 | 2019 | 3 | 0.160 |
Why?
|
| Prevalence | 6 | 2014 | 458 | 0.160 |
Why?
|
| Comorbidity | 3 | 2017 | 488 | 0.150 |
Why?
|
| Hospitals, Urban | 2 | 1998 | 34 | 0.150 |
Why?
|
| Quality of Health Care | 4 | 2020 | 102 | 0.150 |
Why?
|
| Mortality, Premature | 1 | 2018 | 6 | 0.150 |
Why?
|
| Survival Analysis | 2 | 2009 | 261 | 0.150 |
Why?
|
| Illinois | 4 | 2015 | 250 | 0.150 |
Why?
|
| Infant, Low Birth Weight | 1 | 2018 | 16 | 0.150 |
Why?
|
| Global Health | 1 | 2018 | 36 | 0.150 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2018 | 19 | 0.150 |
Why?
|
| General Practice | 1 | 2018 | 2 | 0.150 |
Why?
|
| Infant, Newborn | 5 | 2019 | 562 | 0.150 |
Why?
|
| Biomarkers | 2 | 2018 | 561 | 0.140 |
Why?
|
| Germany | 1 | 2017 | 6 | 0.140 |
Why?
|
| Women's Health | 2 | 2017 | 176 | 0.140 |
Why?
|
| Wales | 4 | 2010 | 5 | 0.140 |
Why?
|
| Medical Overuse | 1 | 2017 | 7 | 0.140 |
Why?
|
| Down-Regulation | 1 | 2017 | 100 | 0.140 |
Why?
|
| Health Education | 3 | 1994 | 46 | 0.130 |
Why?
|
| False Negative Reactions | 1 | 2016 | 14 | 0.130 |
Why?
|
| Evidence-Based Medicine | 1 | 2017 | 162 | 0.130 |
Why?
|
| Quality Control | 1 | 2016 | 27 | 0.130 |
Why?
|
| Prognosis | 4 | 2012 | 804 | 0.130 |
Why?
|
| Facility Regulation and Control | 1 | 1996 | 1 | 0.130 |
Why?
|
| Sensitivity and Specificity | 2 | 2016 | 485 | 0.130 |
Why?
|
| Urban Health | 3 | 2004 | 23 | 0.130 |
Why?
|
| Quality Assurance, Health Care | 1 | 2016 | 31 | 0.130 |
Why?
|
| Observer Variation | 1 | 2016 | 97 | 0.130 |
Why?
|
| Epidemiologic Methods | 2 | 2015 | 18 | 0.130 |
Why?
|
| Neoplasm Staging | 3 | 2018 | 368 | 0.130 |
Why?
|
| Urban Population | 5 | 2005 | 154 | 0.130 |
Why?
|
| Emergency Medical Services | 1 | 1996 | 32 | 0.130 |
Why?
|
| Quality Indicators, Health Care | 1 | 2016 | 31 | 0.120 |
Why?
|
| Civil Defense | 1 | 2015 | 4 | 0.120 |
Why?
|
| Patient Safety | 1 | 2016 | 38 | 0.120 |
Why?
|
| Hemorrhagic Fever, Ebola | 1 | 2015 | 7 | 0.120 |
Why?
|
| Financing, Government | 1 | 2015 | 9 | 0.120 |
Why?
|
| Reimbursement Mechanisms | 1 | 2015 | 9 | 0.120 |
Why?
|
| Hospitals, Maternity | 1 | 1995 | 3 | 0.120 |
Why?
|
| Stereotyping | 1 | 2015 | 17 | 0.120 |
Why?
|
| Schools, Medical | 1 | 2015 | 27 | 0.120 |
Why?
|
| Patient Satisfaction | 1 | 1998 | 320 | 0.120 |
Why?
|
| Birth Weight | 1 | 2014 | 38 | 0.110 |
Why?
|
| Cohort Studies | 6 | 2019 | 1903 | 0.110 |
Why?
|
| Faculty, Medical | 1 | 2015 | 44 | 0.110 |
Why?
|
| HIV Seroprevalence | 1 | 1994 | 3 | 0.110 |
Why?
|
| Syphilis | 1 | 1994 | 3 | 0.110 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 673 | 0.110 |
Why?
|
| Students, Medical | 1 | 2015 | 58 | 0.110 |
Why?
|
| Community Health Nursing | 1 | 1994 | 6 | 0.110 |
Why?
|
| Sexually Transmitted Diseases | 1 | 1994 | 17 | 0.110 |
Why?
|
| Postpartum Period | 1 | 1993 | 21 | 0.110 |
Why?
|
| Lymphatic Metastasis | 1 | 2012 | 93 | 0.100 |
Why?
|
| Hemodialysis, Home | 1 | 2011 | 1 | 0.090 |
Why?
|
| Tetanus | 1 | 2011 | 1 | 0.090 |
Why?
|
| Disasters | 1 | 2011 | 2 | 0.090 |
Why?
|
| Peritoneal Dialysis, Continuous Ambulatory | 1 | 2011 | 13 | 0.090 |
Why?
|
| Developing Countries | 1 | 2011 | 13 | 0.090 |
Why?
|
| Europe | 4 | 2010 | 57 | 0.090 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2010 | 17 | 0.090 |
Why?
|
| Follow-Up Studies | 5 | 2018 | 1802 | 0.090 |
Why?
|
| Models, Theoretical | 1 | 2010 | 84 | 0.080 |
Why?
|
| Patient Selection | 2 | 2011 | 197 | 0.080 |
Why?
|
| Hemodialysis Units, Hospital | 1 | 2009 | 1 | 0.080 |
Why?
|
| Advisory Committees | 1 | 2009 | 20 | 0.080 |
Why?
|
| Living Donors | 1 | 2009 | 17 | 0.080 |
Why?
|
| Health Services Research | 3 | 2002 | 38 | 0.080 |
Why?
|
| Prospective Studies | 4 | 2009 | 1784 | 0.080 |
Why?
|
| HIV Infections | 1 | 1994 | 476 | 0.080 |
Why?
|
| Counseling | 1 | 2008 | 41 | 0.070 |
Why?
|
| Odds Ratio | 1 | 2009 | 277 | 0.070 |
Why?
|
| Logistic Models | 1 | 2009 | 398 | 0.070 |
Why?
|
| Interviews as Topic | 2 | 2002 | 130 | 0.070 |
Why?
|
| Mexico | 1 | 2007 | 15 | 0.070 |
Why?
|
| Predictive Value of Tests | 1 | 2008 | 478 | 0.070 |
Why?
|
| Early Diagnosis | 1 | 2007 | 58 | 0.070 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2006 | 44 | 0.060 |
Why?
|
| Parathyroid Hormone | 3 | 2010 | 23 | 0.060 |
Why?
|
| Unemployment | 1 | 2005 | 2 | 0.060 |
Why?
|
| Acute Disease | 1 | 2005 | 177 | 0.060 |
Why?
|
| Ventilation-Perfusion Ratio | 1 | 2004 | 3 | 0.060 |
Why?
|
| Infant | 2 | 2009 | 517 | 0.060 |
Why?
|
| Reoperation | 1 | 2009 | 921 | 0.060 |
Why?
|
| Anemia, Sickle Cell | 1 | 2004 | 14 | 0.060 |
Why?
|
| Chest Pain | 1 | 2004 | 20 | 0.060 |
Why?
|
| Child, Preschool | 2 | 2009 | 623 | 0.060 |
Why?
|
| Glucose Tolerance Test | 2 | 2014 | 13 | 0.060 |
Why?
|
| Attitude to Health | 3 | 2011 | 98 | 0.060 |
Why?
|
| Critical Care | 1 | 2005 | 122 | 0.060 |
Why?
|
| Educational Status | 1 | 2005 | 289 | 0.050 |
Why?
|
| Lung | 1 | 2004 | 168 | 0.050 |
Why?
|
| Disease Outbreaks | 2 | 2011 | 80 | 0.050 |
Why?
|
| Intensive Care Units | 1 | 2005 | 265 | 0.050 |
Why?
|
| Disease Progression | 1 | 2005 | 672 | 0.050 |
Why?
|
| Child | 2 | 2009 | 1260 | 0.050 |
Why?
|
| Policy | 1 | 2021 | 9 | 0.050 |
Why?
|
| Poverty Areas | 1 | 2001 | 10 | 0.050 |
Why?
|
| Aging | 1 | 2010 | 1556 | 0.050 |
Why?
|
| Health Care Surveys | 2 | 1998 | 64 | 0.040 |
Why?
|
| Regression Analysis | 2 | 2009 | 258 | 0.040 |
Why?
|
| Medicare | 1 | 2021 | 123 | 0.040 |
Why?
|
| Phosphates | 2 | 2010 | 18 | 0.040 |
Why?
|
| Axilla | 1 | 2019 | 14 | 0.040 |
Why?
|
| Traction | 1 | 2019 | 32 | 0.040 |
Why?
|
| Life Expectancy | 1 | 2018 | 28 | 0.040 |
Why?
|
| Ontario | 1 | 2018 | 16 | 0.040 |
Why?
|
| North America | 1 | 2018 | 39 | 0.040 |
Why?
|
| Medical Indigency | 1 | 1998 | 2 | 0.040 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2018 | 83 | 0.040 |
Why?
|
| Italy | 1 | 2018 | 15 | 0.040 |
Why?
|
| Hospital Charges | 1 | 1998 | 17 | 0.040 |
Why?
|
| Geography | 1 | 2018 | 18 | 0.040 |
Why?
|
| Population Surveillance | 1 | 2018 | 115 | 0.040 |
Why?
|
| Calcium | 2 | 2010 | 369 | 0.030 |
Why?
|
| Community Health Centers | 3 | 1993 | 11 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2018 | 589 | 0.030 |
Why?
|
| Pacific Islands | 1 | 1995 | 2 | 0.030 |
Why?
|
| Analgesia, Obstetrical | 1 | 1995 | 27 | 0.030 |
Why?
|
| Analgesia, Epidural | 1 | 1995 | 54 | 0.030 |
Why?
|
| Organizational Policy | 1 | 1995 | 13 | 0.030 |
Why?
|
| Fetal Macrosomia | 1 | 2014 | 1 | 0.030 |
Why?
|
| Labor, Induced | 1 | 2014 | 3 | 0.030 |
Why?
|
| Fasting | 1 | 2014 | 21 | 0.030 |
Why?
|
| Health Resources | 1 | 2014 | 23 | 0.030 |
Why?
|
| Health Services Needs and Demand | 1 | 2014 | 44 | 0.030 |
Why?
|
| Seroepidemiologic Studies | 1 | 1994 | 18 | 0.030 |
Why?
|
| Fetal Death | 1 | 1993 | 5 | 0.030 |
Why?
|
| Demography | 2 | 2011 | 73 | 0.030 |
Why?
|
| Program Evaluation | 1 | 1994 | 117 | 0.030 |
Why?
|
| Medical Records | 1 | 1993 | 33 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 1994 | 164 | 0.020 |
Why?
|
| New York City | 1 | 2011 | 12 | 0.020 |
Why?
|
| Needs Assessment | 1 | 2011 | 41 | 0.020 |
Why?
|
| Clostridium tetani | 1 | 2011 | 1 | 0.020 |
Why?
|
| Tetanus Toxoid | 1 | 2011 | 1 | 0.020 |
Why?
|
| Endemic Diseases | 1 | 2011 | 7 | 0.020 |
Why?
|
| Immunization, Passive | 1 | 2011 | 11 | 0.020 |
Why?
|
| Metronidazole | 1 | 2011 | 5 | 0.020 |
Why?
|
| Wounds, Penetrating | 1 | 2011 | 7 | 0.020 |
Why?
|
| Vaccination | 1 | 2011 | 35 | 0.020 |
Why?
|
| Anti-Infective Agents | 1 | 2011 | 31 | 0.020 |
Why?
|
| Poisson Distribution | 1 | 2009 | 22 | 0.020 |
Why?
|
| Asia | 1 | 2009 | 9 | 0.020 |
Why?
|
| Bicarbonates | 1 | 2009 | 2 | 0.020 |
Why?
|
| Ferritins | 1 | 2009 | 4 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2010 | 350 | 0.020 |
Why?
|
| Risk | 1 | 2009 | 205 | 0.020 |
Why?
|
| Serum Albumin | 1 | 2009 | 25 | 0.020 |
Why?
|
| Vaginal Smears | 3 | 1993 | 12 | 0.020 |
Why?
|
| Papanicolaou Test | 3 | 1993 | 9 | 0.020 |
Why?
|
| Ethics, Institutional | 1 | 1987 | 1 | 0.020 |
Why?
|
| Insurance, Hospitalization | 1 | 1987 | 2 | 0.020 |
Why?
|
| Government Regulation | 1 | 1987 | 2 | 0.020 |
Why?
|
| Federal Government | 1 | 1987 | 3 | 0.020 |
Why?
|
| Vulnerable Populations | 1 | 1987 | 23 | 0.020 |
Why?
|
| European Continental Ancestry Group | 1 | 2006 | 2 | 0.020 |
Why?
|
| Transfer Agreement | 1 | 1986 | 1 | 0.020 |
Why?
|
| Patient Admission | 1 | 1986 | 23 | 0.020 |
Why?
|
| Blood Cell Count | 1 | 2004 | 12 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2009 | 1380 | 0.010 |
Why?
|
| Radiography, Thoracic | 1 | 2004 | 27 | 0.010 |
Why?
|
| Hospital Mortality | 1 | 2005 | 141 | 0.010 |
Why?
|
| Physical Examination | 2 | 1993 | 116 | 0.010 |
Why?
|
| Health Services | 1 | 1998 | 6 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 1998 | 257 | 0.010 |
Why?
|
| Computers | 1 | 1976 | 17 | 0.010 |
Why?
|
| Appointments and Schedules | 1 | 1993 | 13 | 0.010 |
Why?
|
| Data Collection | 1 | 1993 | 90 | 0.010 |
Why?
|
| Hospital Bed Capacity, 500 and over | 1 | 1986 | 9 | 0.000 |
Why?
|
| Time | 1 | 1986 | 15 | 0.000 |
Why?
|